Skip to Content

Beyaz Approval History

FDA Approved: Yes (First approved September 24, 2010)
Brand name: Beyaz
Generic name: drospirenone, ethinyl estradiol and levomefolate calcium
Dosage form: Tablets
Company: Bayer HealthCare Pharmaceuticals Inc.
Treatment for: Birth Control, Premenstrual Dysphoric Disorder, Acne

Beyaz (drospirenone, ethinyl estradiol and levomefolate calcium) is an estrogen/progestin combined oral contraceptive containing a folate, indicated for use by women to prevent pregnancy, treat symptoms of premenstrual dysphoric disorder, treat moderate acne and to raise folate levels in women who choose to use an oral contraceptive for contraception.

Development History and FDA Approval Process for Beyaz

DateArticle
Sep 27, 2010Approval FDA Approves Beyaz - Combination Contraceptive Containing a Folate

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide